Biotechnology engineer Jenny Pietzsch walks through a demo plant of the French company Global Bioenergies during its inauguration ceremony in Leuna, Germany, on May 11, 2017. Global Bioenergies is producing isobutylene, a hydrocarbon gas made from organic resources, sugar and genetically modified bacteria.
Emerging gene-editing technology is raising questions around the world about the ethics of altering the structure of life: DNA. From Europe to the United States to China, cultural and societal influences shape how each country sees this biotechnology and how it should be regulated. These differences hinder international consensus, as...
TO READ THE FULL ARTICLE
Copyright © Stratfor Enterprises, LLC. All rights reserved.